In vivo imaging refers to the visualization of various life processes within an organism. On
the basis of this visualization, any abnormality prevailing within the biological systems can
diagnosed as the presence of disease. With the increasing global burden of diseases, the
demand for effective diagnosis and real time monitoring of treatment’s efficiency during the
therapeutic period also increasing. This lead to the development of the in-vivo imaging
techniques that facilitates better monitoring and diagnosis at molecular levels. In-vivo
imaging techniques involves various technologically advanced paradigms that are used in
diagnosis of various types of diseases such as cancer etc. In vivo imaging involves studying
the cells’ interaction with the radioisotopes, biomarkers, luminescent proteins, or
irradiations with electromagnetic radiations. On the basis of these interactions, the
diagnosis and the treatment evaluation is done. Various techniques of in-vivo imaging
includes techniques from PET (Positron Emission Tomography) to Diffuse Optical
Tomography (DOT).
As per WHO report published in 2017, about 1 in 6 deaths occurred due to cancer in 2015,
which made it the second leading cause of the deaths across the globe. Additionally, various
types of cancer across the world caused about 8.8 million deaths in 2015, which boosted the
market. Moreover, a report by the National Cancer Institute published in 2016 states that
about 1.6 million new cases of cancer were diagnosed in 2010 and the national expenditures
for cancer expected to reach USD 156 billion by 2020 from USD 125 billion in 2010.
Therefore based on these facts, it can be calculated that the market for in-vivo imaging will
expand along with the increasing demands for diagnosis and research on cancer. This will
enable the U.S. to lead the market.
Rising healthcare expenditures and increasing prevalence of cancer followed by R&D in the
imaging technology for the diagnosis of various types of diseases such as cancer are the
major drivers of the market growth. However, factors such as lack of awareness, uneven
distribution of medical services over the regional boundaries, and low healthcare
expenditures in developing countries may hamper the market growth over the assessment
period.
Global In vivo Imaging Market Players:
Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect
Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/780 .
Segmentation:
The Global In Vivo Imaging Market has been segmented on the basis of applications,
techniques, and end users.